MAGEA4 and neoplasm: Kathrin Davari, Tristan Holland, et al. employed a TCR-T approach, processing MAGE-A4 epitopes presented on HLA-A2 molecules encoded by the HLA-A*02:01 allele, enabling CD4 T cells to kill MAGE-A4 positive tumor cells (Davari, et al. 2021).